Neuro-ophthalmic manifestations of neurodegenerative disease

Ophthalmology Clinics of North America

Volumn 17, Issue 3, 2004, Pages 311-320

  Pelak, Victoria S ^a,b,c   Hall, Deborah A ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; APRAXIA; BINOCULAR CONVERGENCE; CLINICAL FEATURE; COGNITIVE DEFECT; COLOR DISCRIMINATION; COLOR VISION DEFECT; CONTRAST SENSITIVITY; CORTICOBASAL DEGENERATION; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEPTH PERCEPTION; DIFFUSE LEWY BODY DISEASE; DIPLOPIA; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; EVOKED VISUAL RESPONSE; EYE MOVEMENT DISORDER; EYELID DISEASE; FRAGILE X SYNDROME; HUMAN; MOTOR DYSFUNCTION; NEUROFIBRILLARY TANGLE; NEUROOPHTHALMOLOGY; NEUROPATHOLOGY; NYSTAGMUS; OPHTHALMOLOGY; OPTIC NERVE DISEASE; OSCILLOPSIA; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SACCADIC EYE MOVEMENT; SENSORY DYSFUNCTION; SMOOTH PURSUIT EYE MOVEMENT; SPINOCEREBELLAR DEGENERATION; SYMPTOM; SYMPTOMATOLOGY; TREMOR; VISION; VISUAL ACUITY; VISUAL CORTEX; VISUAL DISORDER; VISUAL FIELD; VISUAL HALLUCINATION; VISUAL IMPAIRMENT;

EYE DISEASES; HUMANS; NERVOUS SYSTEM DISEASES; NEURODEGENERATIVE DISEASES;

EID: 4444261030     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2004.05.001     Document Type: Review

References (81)

1. Hendrie H.C. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry. 6(2 Suppl 1):1998;S3-S18
2. Caramelli P., Robitaille Y., Laroche-Cholette A., Nitrini R., Gauvreau D., Joanette Y., et al. Structural correlates of cognitive deficits in a selected group of patients with Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 111(4):1998;184-190
3. Lewis D.A., Campbell M.J., Terry R.D., Morrison J.H. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci. 7:1987;1799-1808
4. Levine D.N., Lee J.M., Fisher C.M. The visual variant of Alzheimer's disease: a clinicopathologic case study. Neurology. 43:1993;305-313
5. Mahurin R.K., DeBettignies B.H., Pirozzolo F.J. Structured assessment of independent living skills: preliminary report of a performance measure of functional abilities in dementia. J Gerontol. 46(2):1991;58-66
6. Perry R.F., Hodges J.R. Relationship between functional and neuropsychological performance in early Alzheimer's disease. Alzheimer Dis Assoc Disord. 14(1):2000;1-10
7. Wright C.E., Drasdo N., Harding G.F. Pathology of the optic nerve and visual association areas: information given by the flash and pattern visual evoked potential, and the temporal and spatial contrast sensitivity function. Brain. 110:1987;107-120
8. Schlotterer G., Moscovitch M., Crapper-McLachlan D. Visual processing deficits as assessed by spatial frequency contrast sensitivity and backward masking in normal aging and Alzheimer's disease. Brain. 107:1983;309-323
9. Rizzo J.F., Cronin-Golomb A., Growdon J.H., Corkin S., Rosen J.T., Sandberg M.A., et al. Retinocalcarine function in Alzheimer's disease: a clinical and electrophysiological study. Arch Neur. 49:1992;93-101
10. Sadun A.A., Borchert M., DeVita E., Hinton D.R., Bassi C.J. Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol. 104:1987;113-120
11. Trick G.L., Trick L.R., Morris P., Wolf M. Visual field loss in senile dementia of the Alzheimer type. Neurology. 45:1995;68-74
12. Cogan D.G. Visual disturbances with focal progressive dementing disease. Am J Ophthalmol. 100:1985;68-72
13. Nissen M.J., Corkin S., Buonanno F.S., Growdon J.H., Wray S.H., Bauer J. Spatial vision in Alzheimer's disease: general findings and a case report. Arch Neurol. 42:1985;667-671
14. Cronin-Golomb A., Corkin S., Rizzo J.F., Cohen J., Growdon J.H., Banks K.S. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol. 29:1991;41-52
15. Gilmore G.C., Whitehouse P.H. Contrast sensitivity in Alzheimer's disease: a 1-year longitudinal analysis. Optom Vis Sci. 72(2):1995;83-91
16. Cronin-Golomb A., Sugiura R., Corkin S., Growdon J.H. Incomplete achromatopsia in Alzheimer's disease. Neurobiol Aging. 14(5):1993;471-477
17. Justino L., Kergoat M., Bergam H., Chertkow H., Robillard A., Kergoat H. Neuroretinal function is normal in early dementia of the Alzheimer type. Neurobiol Aging. 2001;691-695
18. Katz B., Rimmer S., Iragui V., Katzman R. Abnormal pattern electroretinogram in Alzheimer's disease: evidence for retinal ganglion cell degeneration? Ann Neurol. 26(2):1989;221-225
19. Trick G.L., Barris M.C., Bickler-Bluth M. Abnormal pattern electroretinograms in patients with senile dementia of the Alzheimer type. Ann Neurol. 26(2):1989;226-231
20. Brodie E.E., Allan D., Brooks D.N., McCulloch J., Foulds W.S. Flash and pattern reversal visual evoked responses in normal and demented elederly. Cortex. 28:1992;289-293
21. Hinton D.R., Sadun A.A., Blanks J.C., Miller C.A. Optic-nerve degeneration in Alzheimer's disease. N Engl J Med. 315:1986;485-487
22. Davies D.C., McCoubrie P., McDonald B., Jobst K.A. Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Br J Ophthalmol. 79(6):1995;596-600
23. Curcio C.A., Durcker D.N. Retinal ganglion cells in Alzheimer's disease and aging. Ann Neurol. 33(3):1993;248-257
24. Mendola J., Cronin-Golomb A., Corkin S., Growdon J.H. Prevalence of visual deficits in Alzheimer's disease. Optom Vis Sci. 72:1995;155-167
25. Mendez M.F., Mendez M.A., Martin R., Smyth K.A., Whitehouse P.J. Complex visual disturbances in Alzheimer's disease. Neurology. 40:1990;439-443
26. Rizzo M., Anderson S.W., Dawson J., Nawrot M. Vision and cognition in Alzheimer's disease. Neuropsychologia. 38:2000;1157-1169
27. Rizzo M., Nawrot M. Perception of movement and shape in Alzheimer's disease. Brain. 121:1998;2259-2270
28. Caselli R.J. Visual syndromes as the presenting feature of degenerative brain disease. Semin Neurol. 20(1):2000;139-144
29. Leigh R.J., Zee D.S. Diagnosis of central disorders of ocular motility. The neurology of eye movements. 1999;549 Oxford University Press, New York
30. Fletcher W.A., Sharpe J.A. Saccadic eye movement dysfunction in Alzheimer's disease. Ann Neurol. 20:1986;464-471
31. Tanner C.M., Aston D.A. Epidemiology of Parkinson's disease and akinetic syndromes. Curr Opin Neurol. 13:2000;427-430
32. Riley D.E., Lang A.E. Movement disorders. Bradley W.G., Daroff R.B., Fenichel G.M., Marsden C.D. Neurology in clinical practice. 3rd edition:2000;1891-1899 Butterworth Heninemann, Boston
33. Jankovic J. Parkinsonism: clinical features and differential diagnosis. Program for a comprehensive review of movement disorders for the clinical practitioner. 2003;337-380 Columbia University College of Physicians & Surgeons, Aspen (CO)
34. Sanchez-Ramos J.R., Ortoll R., Paulson G.W. Visual hallucinations associated with Parkinson disease. Arch Neurol. 53(12):1996;1265-1268
35. Jones R.D., Donaldson I.M., Timmings P.L. Impairment of high-contrast visual acuity in Parkinson's disease. Mov Disord. 7:1992;232-238
36. Haug B.A., Trenkwalder C., Arden G.B., Oertel W.H., Paulus W. Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease. Mov Disord. 9:1994;563-570
37. Mestre D., Blin O., Serratrice G., Pailhous J. Human spatiotemporal contrast sensitivity: dopaminergic variations. Eur J Pharmacol. 183:1990;1022-1023
38. Marx M., Bodis-Wollner I., Bobak P., Harnois C., Mulin L., Yahr M. Temporal frequency-dependent VEP changes in Parkinson's disease. Vision Res. 26:1986;185-193
39. Peppe A., Stanzione P., Pierelli F., Stefano E., Rizzo P.A., Tagliati M., et al. Low contrast stimuli enhance PERG sensitivity to the visual dysfunction in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 82(6):1992;453-457
40. Ikeda H., Head G.M., Ellis C.J. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study. Vision Res. 34:1994;2629-2638
41. Rodnitzky R.L. Visual dysfunction in Parkinson's disease. Clin Neurosci. 5:2000;102-106
42. Lieb K., Brucker S., Bach M., Els T., Lucking C.H., Greenlee M.W. Impairment in preattentive visual processing in patients with Parkinson's disease. Brain. 12:1999;303-313
43. Crucian G.P., Okun M.S. Visual-spatial ability in Parkinson's disease. Front Biosci. 8:2003;S992-S997
44. Abe Y., Kachi T., Kato T., Arahata Y., Yamoda T., Washimi Y., et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry. 74:2003;419-422
45. Racette B.A., Gokden M., Tychsen L., Perlmutter J.S. Convergence insufficiency in idiopathic Parkinson's disease responsive to levodopa. Strabismus. 7:1999;169-174
46. Nakamura T., Kanayama R., Sano R., Ohki M., Kimura Y., Aoyagi M., et al. Quantitative analysis of ocular movements in Parkinson's disease. Acta Otolaryngol Suppl. 481:1991;559-562
47. Vidailhet M., Rivaud S., Gouider-Khouja N., Pillon B., Bonnet A.M., Gaymard B., et al. Eye movements in parkinsonian syndromes. Ann Neurol. 35:1994;420-426
48. Gibson J.M., Pimlott R., Kennard C. Ocular motor and manual tracking in Parkinson's disease and the effect of treatment. J Neurol Neurosurg Psychiatry. 50:1987;853-860
49. Lueck C.J., Tanyeri S., Crawford T.J., Henderson L., Kennard C. Antisaccades and remembered saccades in Parkinson's disease. J Neurol Neurosurg Psychiatry. 53:1990;284-288
50. Zee D.S. Supranuclear and internuclear ocular motor disorders. Miller N.R., Newman N.J. Walsh and Hoyt's clinical neuro-ophthalmology. 5th edition:1985;1316-1317 Williams & Wilkins, Baltimore (MD)
51. Crawford T.J., Henderson L., Kennard C. Abnormalities of nonvisually-guided eye movements in Parkinson's disease. Brain. 112:1989;1573-1586
52. Sharpe J.A., Fletcher W.A., Lang A.E., Zachon D.H. Smooth pursuit during dose-related on-off fluctuations in Parkinson's disease. Neurology. 37:1987;1389-1392
53. Leigh R.J., Daroff R.B., Troost B.T. Supranuclear disorders of eye movements. Glaser J.S. Neuro-ophthalmology. 1999;351-363 Lippincott Williams & Wilkins, Philadelphia
54. Byrne E.J., Lennox G., Lowe J., Godwin-Austen R.B. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry. 52:1989;709-717
55. Gibb W.R.G., Esiri M.M., Lees A.J. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain. 110:1987;1131-1153
56. Fearnley J.M., Revesz T., Brooks D.J., Frackowiak R.S., Lees A.J. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry. 54(2):1991;159-161
57. Paulson H. Yet another spinocerebellar ataxia - will it ever end? Lancet Neurol. 1(8):2002;471
58. Klostermann W., Zuhlke C., Heide W., Kompf D., Wessel K. Slow saccades and other eye movement disorders in spinocerebellar atrophy type 1. J Neurol. 244(2):1997;105-111
59. Jardim L.B., Pereira M.L., Silveira I., Ferro A., Sequeiros J., Giugliani R. Neurologic findings in Machado-Joseph disease: relation with disease duration, subtypes, and (CAG)n. Arch Neurol. 58(6):2001;899-904
60. Rufa A., Dotti M.T., Galli L., Orrico A., Sicurelli F., Federico A. Spinocerebellar ataxia type 2 (SCA2) associated with retinal pigmentary degeneration. Eur Neurol. 47(2):2002;128-129
61. Tolosa E., Valldeoriola F., Pastor P. Progressive supranuclear palsy. Jankovic J., Tolosa E. Parkinson's disease and movement disorders. 2002;152-169 Lippincott Williams & Wilkins, Philadelphia
62. Litvan I. Diagnosis and management of progressive supranuclear palsy. Semin Neurol. 21:2001;41-48
63. Freidman D.I., Jankovic J., McCrary J.A. Neuro-ophthalmic findings in progressive supranuclear palsy. J Clin Neuroophthalmol. 12:1992;104-109
64. Kitthaweesin K., Riley D.E., Leigh R.J. Vergence disorders in progressive supranuclear palsy. Ann N Y Acad Sci. 956:2002;504-507
65. Gironell A., Kulisevsky J., Roig C., Pascual-Sedano B., Rodriguez-Fornells A., Otermin P. Diagnostic potential of acoustic startle reflex, acoustic blink reflex, and electro-oculography in progressive supranuclear palsy: a prospective study. Mov Disord. 18:2003;1273-1279
66. Togasaki D., Tanner C. Epidemiologic aspects. Adv Neurol. 82:2000;53-59
67. Savoiardo M., Grisoli M., Girotti F. Magnetic resonance imaging in CBD-related atypical parkinsonian disorders and dementias. Adv Neurol. 82:2000;197-208
68. Kumar R., Bergeron C., Lang A. Corticobasal degeneration. Jankovic J., Tolosa E. Parkinson's disease and movement disorders. 2002;185-198 Lippincott Williams & Wilkins, Philadelphia
69. Jacquemont S., Hagerman R., Leehey M., Grigsby J., Zhang L., Brunberg J., et al. Fragile X premutation tremor/ataxia syndrome: molecular, clinical, and neuroimaging correlates. Am J Hum Genet. 72:2003;869-878
70. Greco C., Hagerman R., Tassone F., et al. Neuronal inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain. 125:2002;1760-1771
71. Hagerman R., Leehey M., Heinrichs, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology. 57:2001;127-130
72. Brown P., Gibbs C.J., Rodgers-Johnason P. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 35:1994;513-529
73. Brown P., Cathala F., Castaigne P., Gajdusek D.C. Creutzfeldt-Jakob disease: clinical analysis of consecutive series of 230 neuropathologically verified cases. Ann Neurol. 20:1986;597-602
74. Vargas M.E., Kupersmith M.J., Savino P.J., Petito F., Frohman L.P., Warren F.A. Homonymous field defect as the first manifestation of Creutzfeldt-Jakob disease. Am J Ophthalmol. 119:1995;487-504
75. Purvin V., Bonnin J., Goodman J. Palinopsia as a presenting manifestation of Creutzfeldt-Jakob disease. J Clin Neuroophthalmol. 9:1989;242-246
76. Lesser R.L., Albert D.M., Bobowich A.R., O'Brien F.H. Creutzfeldt-Jakob disease and otpic atrophy. Am J Ophthalmol. 87:1979;317-321
77. Grant M.P., Cohen M., Peterson R.B., Halmagyi G.M., McDougall A., Tusa R.J., et al. Abnormal eye movements in Creutzfeldt-Jakob disease. Ann Neurol. 34(2):1993;192-197
78. Yokota T., Tsuchiya K., Yamane M., Hayashi M., Tanabe H., Tsukagoshi H. Geotropic ocular deviation with skew and absence of saccade in Creutzfeldt-Jakob disease. J Neurol Sci. 106:1991;175-178
79. Newman N.J. Hereditary optic neuropathies. Miller N.R., Newman N.J. Walsh and Hoyt's clinical neuro-ophthalmology. 5th edition:1985;741-773 Williams & Wilkins, Baltimore (MD)
80. Liu G.L., Volpe N.J., Galetta S.L. Vision loss: optic neuropathies. Neuro-ophthalmology: diagnosis and management. 2001;127-128 W.B. Saunders Co., Philadelphia
81. Riikonen R. The PEHO syndrome. Brain Dev. 23(7):2001;765-769